» Articles » PMID: 15313889

Ablation of Peripheral Dopaminergic Nerves Stimulates Malignant Tumor Growth by Inducing Vascular Permeability Factor/vascular Endothelial Growth Factor-mediated Angiogenesis

Overview
Journal Cancer Res
Specialty Oncology
Date 2004 Aug 18
PMID 15313889
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Many important physiological and pathological processes are modulated by angiogenesis. It has been shown that initiation of this angiogenic process is an essential early step in the progression of malignant tumors. We report here that ablation of peripheral dopaminergic nerves markedly increased angiogenesis, microvessel density, microvascular permeability, and growth of malignant tumors in mice. Endogenous peripheral dopamine acted through D2 receptors as significantly more angiogenesis and tumor growth was observed in D2 dopamine receptor knockout mice in comparison with controls. The vascular endothelial growth factor receptor 2 phosphorylation, which is critical for promoting angiogenesis, was also significantly more in tumor endothelial cells collected from the dopamine-depleted and D2 dopamine receptor knockout animals. These results reveal that peripheral endogenous neurotransmitter dopamine might be an important physiological regulator of vascular endothelial growth factor-mediated tumor angiogenesis and growth and suggest a novel link between endogenous dopamine, angiogenesis, and tumor growth.

Citing Articles

A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022.

Estole-Casanova L Acta Med Philipp. 2024; 58(10):49-64.

PMID: 38939420 PMC: 11199371. DOI: 10.47895/amp.vi0.6994.


Research progress on the roles of dopamine and dopamine receptors in digestive system diseases.

Lu X, Liu Q, Deng Y, Wu J, Mu X, Yang X J Cell Mol Med. 2024; 28(7):e18154.

PMID: 38494840 PMC: 10945074. DOI: 10.1111/jcmm.18154.


Involvement of neuronal factors in tumor angiogenesis and the shaping of the cancer microenvironment.

Shalabi S, Belayachi A, Larrivee B Front Immunol. 2024; 15:1284629.

PMID: 38375479 PMC: 10875004. DOI: 10.3389/fimmu.2024.1284629.


Neurotransmitters: promising immune modulators in the tumor microenvironment.

Xiao L, Li X, Fang C, Yu J, Chen T Front Immunol. 2023; 14:1118637.

PMID: 37215113 PMC: 10196476. DOI: 10.3389/fimmu.2023.1118637.


Diabetic rats with high levels of endogenous dopamine do not show retinal vascular pathology.

Allen R, Khayat C, Feola A, Win A, Grubman A, Chesler K Front Neurosci. 2023; 17:1125784.

PMID: 37034167 PMC: 10073440. DOI: 10.3389/fnins.2023.1125784.